Drug Type Enzyme |
Synonyms ZMC 101, ZMC101 |
Target |
Mechanism KRAS inhibitors(GTPase KRas inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Zymedi Co. Ltd.Startup |
Active Organization Zymedi Co. Ltd.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Discovery | KR | Zymedi Co. Ltd.Startup | 19 Jul 2023 |